/
HSCS
$2.10+$0.06 (+3.00%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$7.8M
4M shares
52-week range
$1.63 – $3.93
20% from low
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
NASDAQ
CS
Change$-167.94
HeartSciences Inc. Common Stock
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
www.heartsciences.com- Employees
- 14
- IPO / List date
- Jun 15, 2022
- HQ
- SOUTHLAKE, TX
Held by traders on TradeandTell
No one on the platform currently holds HSCS.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HSCS as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-05-17 | 1-for-100reverse |
Recent trades on TradeandTell
No one on the platform has traded HSCS yet.
